Literature DB >> 16636585

Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function.

Young Rae Lee1, Kyu-Beck Lee.   

Abstract

BACKGROUND: The purpose of this study was to determine if renal volumetric indices can be accurately measured using MRI, and if these volumetric indices are associated with hypertension and renal function in patients with autosomal-dominant polycystic kidney disease (ADPKD).
METHODS: For testing the accuracy of the MRI-based volume measurements that we proposed for clinical trial, we designed phantoms to simulate cysts within the kidney. Fifty-six patients with ADPKD were included in this study, and their respiratory compensated T2-weighted fast spin-echo images were acquired. The total kidney volume (Vt), cyst volume (Vc), and noncystic parenchymal volume (Vp) were measured and the percent cyst volume (Pc) was calculated. These volumetric indices were compared with the disease progression in the ADPKD patients.
RESULTS: The MRI measures of the phantoms were accurate. The Vt, Vc and Pc were significantly greater in the hypertensive group (n = 35) than in the normotensive group (n = 21) (p < 0.01). The Vt, Vc and Pc were significantly greater in the renal failure group (n = 23) than in the normal renal function group (n = 33) (p < 0.01). The Vt, Vc, and Pc were inversely correlated with the creatinine clearance.
CONCLUSION: MRI is a reliable method to measure renal volumetric indices. The MRI-based volume measurements can be employed as useful markers for the progression of disease in ADPKD patients. Copyright 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636585     DOI: 10.1159/000092915

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  11 in total

1.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

2.  Change in renal parenchymal volume in living kidney transplant donors.

Authors:  Turun Song; Lei Fu; Zixing Huang; Shaofeng He; Ruining Zhao; Tao Lin; Qiang Wei
Journal:  Int Urol Nephrol       Date:  2013-11-01       Impact factor: 2.370

3.  Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD).

Authors:  Anna S Nikonova; Alexander Y Deneka; Anna A Kiseleva; Vladislav Korobeynikov; Anna Gaponova; Ilya G Serebriiskii; Meghan C Kopp; Harvey H Hensley; Tamina N Seeger-Nukpezah; Stefan Somlo; David A Proia; Erica A Golemis
Journal:  FASEB J       Date:  2018-01-10       Impact factor: 5.191

4.  Distinct patterns of kidney and liver cyst growth in pkd2(WS25/-) mice.

Authors:  R Brian Doctor; Natalie J Serkova; Kendra M Hasebroock; Iram Zafar; Charles L Edelstein
Journal:  Nephrol Dial Transplant       Date:  2010-04-13       Impact factor: 5.992

Review 5.  Imaging for the prognosis of autosomal dominant polycystic kidney disease.

Authors:  Kyongtae T Bae; Jared J Grantham
Journal:  Nat Rev Nephrol       Date:  2010-02       Impact factor: 28.314

6.  The relationship between renal volume and renal function in autosomal dominant polycystic kidney disease.

Authors:  Shino Tokiwa; Satoru Muto; Toshiyuki China; Shigeo Horie
Journal:  Clin Exp Nephrol       Date:  2011-03-24       Impact factor: 2.801

7.  Monitoring kidney and renal cyst volumes applying MR approaches on a rapamycin treated mouse model of ADPKD.

Authors:  Wilfried Reichardt; Daniel Romaker; Anne Becker; Martin Buechert; Gerd Walz; Dominik von Elverfeldt
Journal:  MAGMA       Date:  2008-12-24       Impact factor: 2.310

Review 8.  Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies.

Authors:  Toshio Mochizuki; Ken Tsuchiya; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-11-29       Impact factor: 2.801

9.  ADPKD: Prototype of Cardiorenal Syndrome Type 4.

Authors:  Grazia Maria Virzì; Valentina Corradi; Anthi Panagiotou; Fiorella Gastaldon; Dinna N Cruz; Massimo de Cal; Maurizio Clementi; Claudio Ronco
Journal:  Int J Nephrol       Date:  2010-12-21

10.  Opposing Effects of Inhibitors of Aurora-A and EGFR in Autosomal-Dominant Polycystic Kidney Disease.

Authors:  Anna S Nikonova; Alexander Y Deneka; Louisa Eckman; Meghan C Kopp; Harvey H Hensley; Brian L Egleston; Erica A Golemis
Journal:  Front Oncol       Date:  2015-10-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.